Cite

HARVARD Citation

    Ferrer‐Donato, A. et al. (2022). The potential benefit of leptin therapy against amyotrophic lateral sclerosis (ALS). Brain and behavior. 12 (1), p. n/a. [Online]. 
  
Back to record